| The
devastating effects of respiratory disease hit close to home for
Alison Wallace. As a child, the West Vancouver native suffered from
asthma and for 10 years she witnessed her grandfather Donald struggle
with emphysema.
While Alison eventually outgrew her asthma by age 20, Donald was
not so fortunate. Emphysema slowly robbed the former rancher of
his breath, and his life.
Typically robust, Donald enjoyed horseback riding, water-skiing
and cycling until the debilitating lung disease left him dependent
on an oxygen tank to breathe.
“It was pretty frustrating for him,” Alison says. Last
August, at age 86, Donald lost his battle with emphysema, leaving
his doctors with no clear explanation for why he developed the disease.
“The major environmental risk factor for emphysema is smoking,”
Alison explains. “But he wasn’t a smoker.”
Her grandfather’s experience, combined with evidence that
only 20 per cent of smokers develop emphysema, sent Alison on a
mission. As a Ph.D. student in UBC’s Experimental Medicine
program, Alison, now 26, is using her boundless energy and passion
to unlock the genetic basis of the disease. Her research has led
her to St. Paul’s Hospital’s iCAPTUR4E Centre/McDonald
Research Laboratories, which focuses on research into genetic and
environmental causes of heart, lung and vascular disease.
There, Alison works under the guidance of Dr. Peter Paré,
co-director of the Centre, and Dr. Andrew Sandford, a recent addition
to the faculty and an expert in genetics. “It’s unusual
for someone who hasn’t smoked to develop emphysema,”
Dr. Paré says. “When you do see it, it suggests a strong
genetic connection.”
Emphysema is one of a group of lung disorders referred to as chronic
obstructive pulmonary disease (COPD) and has no known cure.
By tapping into the Centre’s unparalleled tissue registry,
Alison is using state-of-the-art-imaging equipment to examine lung
tissue samples. By comparing cells from people who have emphysema
and others who don’t, she hopes to pinpoint specific gene
mutations that predispose a person to the disease.
Findings from this research could have far-reaching benefits. “If
we prove that a specific genetic mutation increases a person’s
risk for developing emphysema, it can lead to improved methods for
early detection and new treatment therapies,” Alison explains.
“It’s pretty exciting.”
Alison’s work is leading edge material says Dr. Paré.
While previous studies have shown there is a mutation in the gene
that Alison is studying and that it might be important in this disease,
she is taking it one step further. “Getting the cells from
people with that mutation and some without it to see how they behave
in a test tube is unique. I don’t think anyone else in the
world is doing that.”
According to Dr. Paré, this project is also a testament
to one of St. Paul’s Hospital’s greatest assets –
its people. “It draws on one of our major strengths and that
is the close collaboration we have between surgeons, pathologists
and clinicians,” he says. “That is very rare.”
Like many of her colleagues, Alison is committed to easing the
burden of emphysema so that the pain her grandfather suffered is
a thing of the past.
With that, we can all breathe a little easier.
Dr. David Kuhl, an internationally known palliative care physician
who works at St. Paul’s Hospital, has written a profound and
practical book about living with a terminal illness.
What Dying People Want (Doubleday Canada) presents ways of finding
new life in the process of dying by providing guidance and helpful
strategies for people with terminal illness and their families.
Published last month, it’s now available in book stores.
Back to main page
|